Just a thought about Amgen.
If their drug works by binding to CD19 and also binding the Cart-T cells and brings them together, isn't it possible that their drug will work on TNBC without IMU's virus but they didn't know?
Is it possible they will want to do a trial to see how well their drug works without IMU's virus?
Would appreciate any insights.
Ann: onCARlytics to be showcased in three abstracts at SITC, page-84
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.2¢ |
Change
0.006(10.7%) |
Mkt cap ! $440.9M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 6.3¢ | 5.6¢ | $1.147M | 19.23M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 211203 | 6.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.2¢ | 1574808 | 17 |
View Market Depth
| Last trade - 15.35pm 23/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |